All the news articles and press releases in one place.

Search
Date / Time Source Ticker Company Sector Market Cap Announcement
22Apr24 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - US and EU patents for innovative CellKeep™ slide
08Apr24 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Parsortix HER2 assay showcased at AACR 2024
22Mar24 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Parsortix at European breast cancer conference
22Jan24 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Potential utility in precision oncology
10Jan24 12:57 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Standard form for notification of major holdings
04Jan24 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Breakthrough clinical results
02Jan24 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Contract announcement with Eisai Inc.
11Dec23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Broker Announcement
11Dec23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Parsortix unlocks opportunities for drug discovery
05Dec23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
09Nov23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Trading and business update
09Nov23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Launch of PD-L1 test to support cancer studies
25Oct23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Supporting characterisation of CTCs in HNSCC
03Oct23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Parsortix outperforms standard for DTC harvest
29Sep23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Parsortix system showcased at ACTC conference
07Sep23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Interim Results for the period ended 30 June 2023
04Sep23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - ANGLE launch of Portrait Flex assay
15Aug23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - ANGLE notice of interim results
28Jun23 16:54 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Result of 2023 Annual General Meeting
27Jun23 12:24 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Standard form for notification of major holdings
05Jun23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - ANGLE announces senior management appointments
25May23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Pharma services contract with Artios Pharma
22May23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Board change - appointment of new Chairman
21Apr23 12:04 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - ANGLE presentation via Investor Meet Company
21Apr23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Results for the year ended 31 December 2022
19Apr23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - ANGLE announces partnership with BioView
17Apr23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - ANGLE Parsortix poster presented at AACR 2023
13Apr23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Pharma Services Contract with Crescendo Biologics
03Apr23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Notice of Preliminary Results and Webcast
10Mar23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Holding(s) in Company
09Feb23 14:44 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Director/PDMR shareholding
19Jan23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Holding(s) in Company
10Jan23 18:20 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Holding(s) in Company
05Jan23 07:01 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Business Update
12Dec22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
02Nov22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
18Oct22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - First regional distribution agreement
30Sep22 17:30 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
30Sep22 17:30 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Holding(s) in Company
29Sep22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Positive headline results from ovarian study
29Sep22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Interim Results
28Sep22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Holding(s) in Company
20Jul22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Director/PDMR Shareholding
15Jul22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Results of Capital Raise
14Jul22 17:24 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
29Jun22 16:35 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
22Jun22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Secured contract from pharma services customer
16Jun22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Partnership with major United States urology group
27May22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Molecular characterisation of CTCs
25May22 12:30 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Preliminary Results
20Apr22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Update on laboratory accreditation
02Mar22 18:29 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Holding(s) in Company
18Feb22 17:13 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
21Jan22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
01Dec21 18:11 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
01Dec21 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
17Nov21 10:32 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
15Nov21 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
12Nov21 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
02Nov21 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Change of Adviser
21Oct21 17:25 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
15Oct21 17:45 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
30Sep21 16:02 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Issue of Equity
30Sep21 07:00 RNS AGL:LON ANGLE plc Health £32.6m Angle PLC - Interim Results
Date / Time Source Company % Chg
22Apr24 07:00 RNS ANGLE plc 0.00%
Angle PLC - US and EU patents for innovative CellKeep™ slide
08Apr24 07:00 RNS ANGLE plc 0.00%
Angle PLC - Parsortix HER2 assay showcased at AACR 2024
22Mar24 07:00 RNS ANGLE plc 0.00%
Angle PLC - Parsortix at European breast cancer conference
22Jan24 07:00 RNS ANGLE plc 0.00%
Angle PLC - Potential utility in precision oncology
10Jan24 12:57 RNS ANGLE plc 0.00%
Angle PLC - Standard form for notification of major holdings
04Jan24 07:00 RNS ANGLE plc 0.00%
Angle PLC - Breakthrough clinical results
02Jan24 07:00 RNS ANGLE plc 0.00%
Angle PLC - Contract announcement with Eisai Inc.
11Dec23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Broker Announcement
11Dec23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Parsortix unlocks opportunities for drug discovery
05Dec23 07:00 RNS ANGLE plc 0.00%
Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
09Nov23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Trading and business update
09Nov23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Launch of PD-L1 test to support cancer studies
25Oct23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Supporting characterisation of CTCs in HNSCC
03Oct23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Parsortix outperforms standard for DTC harvest
29Sep23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Parsortix system showcased at ACTC conference
07Sep23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Interim Results for the period ended 30 June 2023
04Sep23 07:00 RNS ANGLE plc 0.00%
Angle PLC - ANGLE launch of Portrait Flex assay
15Aug23 07:00 RNS ANGLE plc 0.00%
Angle PLC - ANGLE notice of interim results
28Jun23 16:54 RNS ANGLE plc 0.00%
Angle PLC - Result of 2023 Annual General Meeting
27Jun23 12:24 RNS ANGLE plc 0.00%
Angle PLC - Standard form for notification of major holdings
05Jun23 07:00 RNS ANGLE plc 0.00%
Angle PLC - ANGLE announces senior management appointments
25May23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Pharma services contract with Artios Pharma
22May23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Board change - appointment of new Chairman
21Apr23 12:04 RNS ANGLE plc 0.00%
Angle PLC - ANGLE presentation via Investor Meet Company
21Apr23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Results for the year ended 31 December 2022
19Apr23 07:00 RNS ANGLE plc 0.00%
Angle PLC - ANGLE announces partnership with BioView
17Apr23 07:00 RNS ANGLE plc 0.00%
Angle PLC - ANGLE Parsortix poster presented at AACR 2023
13Apr23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Pharma Services Contract with Crescendo Biologics
03Apr23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Notice of Preliminary Results and Webcast
10Mar23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03 RNS ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
09Feb23 14:44 RNS ANGLE plc 0.00%
Angle PLC - Director/PDMR shareholding
19Jan23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20 RNS ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
10Jan23 18:20 RNS ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
05Jan23 07:01 RNS ANGLE plc 0.00%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00 RNS ANGLE plc 0.00%
Angle PLC - Business Update
12Dec22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
02Nov22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
18Oct22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23 RNS ANGLE plc 0.00%
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00 RNS ANGLE plc 0.00%
Angle PLC - First regional distribution agreement
30Sep22 17:30 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
30Sep22 17:30 RNS ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
29Sep22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Interim Results
28Sep22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00 RNS ANGLE plc 0.00%
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30 RNS ANGLE plc 0.00%
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33 RNS ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
20Jul22 07:00 RNS ANGLE plc 0.00%
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00 RNS ANGLE plc 0.00%
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Results of Capital Raise
14Jul22 17:24 RNS ANGLE plc 0.00%
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23 RNS ANGLE plc 0.00%
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
29Jun22 16:35 RNS ANGLE plc 0.00%
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
22Jun22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Secured contract from pharma services customer
16Jun22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Partnership with major United States urology group
27May22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Molecular characterisation of CTCs
25May22 12:30 RNS ANGLE plc 0.00%
Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Preliminary Results
20Apr22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Update on laboratory accreditation
02Mar22 18:29 RNS ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
18Feb22 17:13 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
21Jan22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00 RNS ANGLE plc 0.00%
Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
01Dec21 18:11 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
01Dec21 07:00 RNS ANGLE plc 0.00%
Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
17Nov21 10:32 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
15Nov21 07:00 RNS ANGLE plc 0.00%
Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00 RNS ANGLE plc 0.00%
Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
12Nov21 07:00 RNS ANGLE plc 0.00%
Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00 RNS ANGLE plc 0.00%
Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
02Nov21 07:00 RNS ANGLE plc 0.00%
Angle PLC - Change of Adviser
21Oct21 17:25 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
15Oct21 17:45 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
30Sep21 16:02 RNS ANGLE plc 0.00%
Angle PLC - Issue of Equity
30Sep21 07:00 RNS ANGLE plc 0.00%
Angle PLC - Interim Results
Date / Time Company % Chg
22Apr24 07:00 ANGLE plc 0.00%
Angle PLC - US and EU patents for innovative CellKeep™ slide
08Apr24 07:00 ANGLE plc 0.00%
Angle PLC - Parsortix HER2 assay showcased at AACR 2024
22Mar24 07:00 ANGLE plc 0.00%
Angle PLC - Parsortix at European breast cancer conference
22Jan24 07:00 ANGLE plc 0.00%
Angle PLC - Potential utility in precision oncology
10Jan24 12:57 ANGLE plc 0.00%
Angle PLC - Standard form for notification of major holdings
04Jan24 07:00 ANGLE plc 0.00%
Angle PLC - Breakthrough clinical results
02Jan24 07:00 ANGLE plc 0.00%
Angle PLC - Contract announcement with Eisai Inc.
11Dec23 07:00 ANGLE plc 0.00%
Angle PLC - Broker Announcement
11Dec23 07:00 ANGLE plc 0.00%
Angle PLC - Parsortix unlocks opportunities for drug discovery
05Dec23 07:00 ANGLE plc 0.00%
Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
09Nov23 07:00 ANGLE plc 0.00%
Angle PLC - Trading and business update
09Nov23 07:00 ANGLE plc 0.00%
Angle PLC - Launch of PD-L1 test to support cancer studies
25Oct23 07:00 ANGLE plc 0.00%
Angle PLC - Supporting characterisation of CTCs in HNSCC
03Oct23 07:00 ANGLE plc 0.00%
Angle PLC - Parsortix outperforms standard for DTC harvest
29Sep23 07:00 ANGLE plc 0.00%
Angle PLC - Parsortix system showcased at ACTC conference
07Sep23 07:00 ANGLE plc 0.00%
Angle PLC - Interim Results for the period ended 30 June 2023
04Sep23 07:00 ANGLE plc 0.00%
Angle PLC - ANGLE launch of Portrait Flex assay
15Aug23 07:00 ANGLE plc 0.00%
Angle PLC - ANGLE notice of interim results
28Jun23 16:54 ANGLE plc 0.00%
Angle PLC - Result of 2023 Annual General Meeting
27Jun23 12:24 ANGLE plc 0.00%
Angle PLC - Standard form for notification of major holdings
05Jun23 07:00 ANGLE plc 0.00%
Angle PLC - ANGLE announces senior management appointments
25May23 07:00 ANGLE plc 0.00%
Angle PLC - Pharma services contract with Artios Pharma
22May23 07:00 ANGLE plc 0.00%
Angle PLC - Board change - appointment of new Chairman
21Apr23 12:04 ANGLE plc 0.00%
Angle PLC - ANGLE presentation via Investor Meet Company
21Apr23 07:00 ANGLE plc 0.00%
Angle PLC - Results for the year ended 31 December 2022
19Apr23 07:00 ANGLE plc 0.00%
Angle PLC - ANGLE announces partnership with BioView
17Apr23 07:00 ANGLE plc 0.00%
Angle PLC - ANGLE Parsortix poster presented at AACR 2023
13Apr23 07:00 ANGLE plc 0.00%
Angle PLC - Pharma Services Contract with Crescendo Biologics
03Apr23 07:00 ANGLE plc 0.00%
Angle PLC - Notice of Preliminary Results and Webcast
10Mar23 07:00 ANGLE plc 0.00%
Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03 ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
09Feb23 14:44 ANGLE plc 0.00%
Angle PLC - Director/PDMR shareholding
19Jan23 07:00 ANGLE plc 0.00%
Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20 ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
10Jan23 18:20 ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
05Jan23 07:01 ANGLE plc 0.00%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00 ANGLE plc 0.00%
Angle PLC - Business Update
12Dec22 07:00 ANGLE plc 0.00%
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30 ANGLE plc 0.00%
Angle PLC - Issue of Equity
02Nov22 07:00 ANGLE plc 0.00%
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00 ANGLE plc 0.00%
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15 ANGLE plc 0.00%
Angle PLC - Issue of Equity
18Oct22 07:00 ANGLE plc 0.00%
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23 ANGLE plc 0.00%
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00 ANGLE plc 0.00%
Angle PLC - First regional distribution agreement
30Sep22 17:30 ANGLE plc 0.00%
Angle PLC - Issue of Equity
30Sep22 17:30 ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
29Sep22 07:00 ANGLE plc 0.00%
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00 ANGLE plc 0.00%
Angle PLC - Interim Results
28Sep22 07:00 ANGLE plc 0.00%
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00 ANGLE plc 0.00%
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30 ANGLE plc 0.00%
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00 ANGLE plc 0.00%
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00 ANGLE plc 0.00%
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33 ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
20Jul22 07:00 ANGLE plc 0.00%
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00 ANGLE plc 0.00%
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00 ANGLE plc 0.00%
Angle PLC - Results of Capital Raise
14Jul22 17:24 ANGLE plc 0.00%
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23 ANGLE plc 0.00%
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30 ANGLE plc 0.00%
Angle PLC - Issue of Equity
29Jun22 16:35 ANGLE plc 0.00%
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00 ANGLE plc 0.00%
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24 ANGLE plc 0.00%
Angle PLC - Issue of Equity
22Jun22 07:00 ANGLE plc 0.00%
Angle PLC - Secured contract from pharma services customer
16Jun22 07:00 ANGLE plc 0.00%
Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00 ANGLE plc 0.00%
Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00 ANGLE plc 0.00%
Angle PLC - Partnership with major United States urology group
27May22 07:00 ANGLE plc 0.00%
Angle PLC - Molecular characterisation of CTCs
25May22 12:30 ANGLE plc 0.00%
Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00 ANGLE plc 0.00%
Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00 ANGLE plc 0.00%
Angle PLC - Preliminary Results
20Apr22 07:00 ANGLE plc 0.00%
Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00 ANGLE plc 0.00%
Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00 ANGLE plc 0.00%
Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00 ANGLE plc 0.00%
Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00 ANGLE plc 0.00%
Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00 ANGLE plc 0.00%
Angle PLC - Update on laboratory accreditation
02Mar22 18:29 ANGLE plc 0.00%
Angle PLC - Holding(s) in Company
18Feb22 17:13 ANGLE plc 0.00%
Angle PLC - Issue of Equity
21Jan22 07:00 ANGLE plc 0.00%
Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00 ANGLE plc 0.00%
Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00 ANGLE plc 0.00%
Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00 ANGLE plc 0.00%
Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29 ANGLE plc 0.00%
Angle PLC - Issue of Equity
01Dec21 18:11 ANGLE plc 0.00%
Angle PLC - Issue of Equity
01Dec21 07:00 ANGLE plc 0.00%
Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33 ANGLE plc 0.00%
Angle PLC - Issue of Equity
17Nov21 10:32 ANGLE plc 0.00%
Angle PLC - Issue of Equity
15Nov21 07:00 ANGLE plc 0.00%
Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00 ANGLE plc 0.00%
Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51 ANGLE plc 0.00%
Angle PLC - Issue of Equity
12Nov21 07:00 ANGLE plc 0.00%
Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00 ANGLE plc 0.00%
Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40 ANGLE plc 0.00%
Angle PLC - Issue of Equity
02Nov21 07:00 ANGLE plc 0.00%
Angle PLC - Change of Adviser
21Oct21 17:25 ANGLE plc 0.00%
Angle PLC - Issue of Equity
15Oct21 17:45 ANGLE plc 0.00%
Angle PLC - Issue of Equity
30Sep21 16:02 ANGLE plc 0.00%
Angle PLC - Issue of Equity
30Sep21 07:00 ANGLE plc 0.00%
Angle PLC - Interim Results